Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cellular cardiomyoplasty in a transgenic mouse model.

Wilhelm Roell1, Yun Fan, Ying Xia

  • 1Department of Cardiac Surgery, University of Bonn, 53105 Bonn, Germany. akp44@uni-koeln.de.

Transplantation
|March 9, 2002
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bicuspid aortic valve stenosis is characterized by increased angiogenesis, inflammation, and a higher valvular-to-systemic calcification ratio than tricuspid aortic valve stenosis.

Basic research in cardiology·2026
Same author

Pressure Overload-Induced Ventricular Crosstalk Activates Regenerative Mechanisms in the Contralateral Ventricle in Neonatal Mice.

Circulation·2026
Same author

Blockage of autophagy causes severe skeletal muscle disruption in a mouse model for myofibrillar myopathy 6.

Nature communications·2026
Same author

Generation and characterization of a human induced pluripotent stem cell line (hiPSC) expressing the rEstus voltage sensor under doxycycline induction.

Stem cell research·2026
Same author

Generation of a homozygous TET2 knock-out hiPSC line for modeling of cardiovascular diseases associated with clonal hematopoiesis of indeterminate potential (CHIP).

Stem cell research·2026
Same author

Beta arrestin 1 is a key regulator of pulmonary vascular tone.

Proceedings of the National Academy of Sciences of the United States of America·2026

Researchers developed a new surgical method for cellular cardiomyoplasty in mice, achieving a 72.2% success rate in engrafting cardiomyocytes. This advance offers a standardized approach for treating cardiovascular disorders.

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Stem Cell Therapy

Background:

  • Stem cell differentiation offers new avenues for treating cardiovascular diseases.
  • Developing standardized methods for cellular cardiomyoplasty is crucial for clinical translation.

Purpose of the Study:

  • To create a novel surgical technique for standardized cellular cardiomyoplasty in mice.
  • To achieve low perioperative mortality with the new surgical approach.

Main Methods:

  • Cryoinjury was used to create reproducible transmural lesions.
  • Embryonic cardiomyocytes were injected intramurally using a custom holding device and vital dye staining.
  • A transgenic mouse model expressing enhanced green fluorescent protein (EGFP) in cardiomyocytes validated the approach.

Related Experiment Videos

Main Results:

  • The perioperative mortality rate was 10%.
  • Engrafted EGFP-positive cardiomyocytes were identified in 72.2% of the operated animals (n=36).

Conclusions:

  • The novel surgical approach enables reliable cellular replacement therapy in mice.
  • This method simplifies the analysis of molecular, cellular, and functional efficacy of cell transplantation.